Helix is an enterprise genomics platform focused on transforming healthcare by integrating genomic insights across health systems and life sciences. The company serves health systems, payers, and pharma, enabling precision medicine, population health initiatives, and accelerated drug discovery. Its solutions include programs like Helix Research Network, Helix Precision Pathway, Helix Diagnostics, Helix Genomic Advantage, and GenoSphere to advance clinical decision making and operational growth. Headquartered around the United States, Helix positions itself at the intersection of genomics and enterprise health strategy.
No recent deals for this company.